Factors Affecting the Ability to Discontinue Oral Corticosteroid Use in Patients with EGPA Treated with Anti-Interleukin-5 Therapy

Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

(2023) Giacomo Emmi et al.   Nature Reviews Rheumatology

Biologics in severe asthma: Which one, When and Where?

(2021) Hitasha Rupani et al.   CLINICAL AND EXPERIMENTAL ALLERGY

The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis

(2020) Hiroyuki Nagase et al.   ALLERGOLOGY INTERNATIONAL

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

(2017) Michael E. Wechsler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

(2017) Geoffrey L Chupp et al.   Lancet Respiratory Medicine

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

(2016) Cindy Strehl et al.   ANNALS OF THE RHEUMATIC DISEASES

Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma

(2016) R. Sehmi et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)

(2016) Vincent Cottin et al.   EUROPEAN RESPIRATORY JOURNAL

Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma

(2016) Anand A. Dalal et al.   Journal of Managed Care & Specialty Pharmacy

Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management

(2015) Matthieu Groh et al.   European Journal of Internal Medicine

Eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome): where are we now?

(2015) Matthieu Groh et al.   EUROPEAN RESPIRATORY JOURNAL

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

(2014) Elisabeth H. Bel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials

(2013) Joanna Robson et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) enrolled in two prospective trials

(2013) Maxime Samson et al.   JOURNAL OF AUTOIMMUNITY

A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients

(2012) Frank Moosig et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of primary small and medium vessel vasculitis

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES